The Follow-Up Schedule After a Skin Cancer

Is there a standard follow-up schedule after skin cancer?

There is no universal timetable. After a skin cancer, the spacing between follow-up visits is set individually by the clinician who treated you, and it turns mainly on two facts: which cancer you had — basal cell, squamous cell, or melanoma — and how advanced it was when it was removed. A small basal cell carcinoma taken off in one clean procedure is usually followed loosely. A thicker melanoma is watched closely, with the tightest spacing in the first few years, when a recurrence is most likely to show up.

The schedule is meant to change over time. It is typically most frequent early and then stretches out as years pass without a problem. Two separate concerns drive it. The first is that the original cancer could return at or near the site it was removed from. The second is that the same skin — shaped by the same genetics and the same lifetime of sun — can grow a brand-new, unrelated skin cancer somewhere else entirely. Follow-up is built to catch both, which is why it does not end the moment the surgical site has healed.

How does the stage of your cancer set the pace?

Stage is the biggest single lever on how intensively you are followed, because stage measures how far the cancer had progressed. For melanoma, the stage is assembled from the tumor's thickness, whether its surface was ulcerated, and whether any lymph nodes were involved 1Ref 1Gershenwald JE, Scolyer RA, Hess KR, et al. (2017).Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.Melanoma is staged from tumor thickness, ulceration, and lymph node status, which sorts tumors into the AJCC 8th-edition stage groups that drive how intensively a patient is followed.. Those measurements sort a melanoma into stage groups, and the stage strongly predicts what comes next.

Survival tracks stage closely. the 5-year relative survival for melanoma found while it is still confined to the skin is about 99% 2Ref 2National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025).Cancer Stat Facts: Melanoma of the Skin.US melanoma 5-year relative survival is about 99% when the cancer is still localized to the skin and falls steeply with regional or distant spread., and it falls steeply once the cancer has reached the lymph nodes or distant organs 2Ref 2National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025).Cancer Stat Facts: Melanoma of the Skin.US melanoma 5-year relative survival is about 99% when the cancer is still localized to the skin and falls steeply with regional or distant spread.. That gradient is the whole reason a thin, early melanoma may be followed with periodic skin exams alone, while a thicker or node-positive one is seen more often and sometimes tracked with imaging.

Basal cell and squamous cell carcinomas are staged and followed on their own terms — most basal cell cancers almost never spread, while some squamous cell cancers carry more weight — but the same logic governs all three: the more concerning the original tumor, the closer the watch, and the longer it stays close.

What happens at a follow-up skin exam

A follow-up visit is built around a total-body skin exam — a systematic look at the skin from the scalp to the soles, including the places people miss on their own, like the back, behind the ears, between the toes, and the nails. For melanoma, the clinician usually also feels the lymph nodes nearest the original tumor, because that is a common first place for a melanoma to return. The old surgical scar gets its own look, checked for any new nodule, thickening, or color creeping in at the edge.

Surveillance is not only about the cancer you already had. The ultraviolet exposure that helped cause the first tumor is a modifiable risk factor, and it keeps mattering after treatment 3Ref 3National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025).Skin Cancer Prevention (PDQ®)–Health Professional Version.Ultraviolet exposure (sun, sunlamps, tanning beds) is a modifiable risk factor for skin cancer, so reducing UV remains relevant after treatment.. Skin that has already produced one cancer can produce another, so the exam is as much about finding the next one early as confirming the last one is gone. That dual purpose is why the visit scans all of your skin, not just the treated spot — and why it continues for years, long after the wound itself is a faint line.

Your own checks between visits

Clinic appointments are only a handful of moments in a year; the skin is yours to watch in between. A practical self-exam walks the ABCDE features — asymmetry, an irregular or ragged border, more than one color, a diameter wider than a pencil eraser, and evolution, meaning any change in size, shape, color, or symptoms over time 4Ref 4Tsao H, Olazagasti JM, Cordoro KM, et al. (2015).Early detection of melanoma: reviewing the ABCDEs.The ABCDE features — asymmetry, border irregularity, color variation, diameter over 6 mm, and evolution — support patient self-detection of melanoma between visits.. for someone tracking their own skin, evolution is the most useful letter, because a spot you can compare to how it looked last month tells you far more than any single glance.

The healed scar and the skin around it belong in the same routine, alongside the moles you already know. Photographs do a lot of the work: a dated phone photo of the site, and of any spot you are keeping an eye on, turns a vague impression into a real before-and-after. That habit of noticing what is new is the same instinct behind advice on who should get regular skin checks — the value is not in a single expert look but in catching change early, and change is something you are often the first to see.

Doesn't the USPSTF say skin screening isn't worth it?

That recommendation is real, but it is often misread. In 2023 the U.S. Preventive Services Task Force concluded that the current evidence is insufficient to weigh the benefits and harms of routine whole-body skin screening by a clinician in asymptomatic, average-risk adults 5Ref 5US Preventive Services Task Force (2023).Skin Cancer: Screening.The 2023 USPSTF found evidence insufficient (Grade I) to assess clinician whole-body skin screening in asymptomatic, average-risk adults and does not address evaluation of a suspicious lesion.. By its own terms, it does not address the evaluation of a suspicious lesion, and it says nothing about people being followed after a diagnosis 5Ref 5US Preventive Services Task Force (2023).Skin Cancer: Screening.The 2023 USPSTF found evidence insufficient (Grade I) to assess clinician whole-body skin screening in asymptomatic, average-risk adults and does not address evaluation of a suspicious lesion..

That distinction matters here. Once you have had a skin cancer, you are no longer in the symptom-free, average-risk population that the screening debate is about — you are a higher-risk patient being watched on purpose. This is the nuance behind the argument over USPSTF skin cancer screening: it is a statement about screening the well, not about the surveillance of someone already treated. So the phrase 'screening isn't recommended' can be true in general and irrelevant to your situation at the same time. Your follow-up plan is not screening; it is targeted surveillance, and it rests on the fact that a personal history is one of the strongest reasons to keep looking.

Lowering the odds of the next skin cancer

Prevention becomes part of the follow-up itself. The clearest evidence comes from a randomized trial in which adults assigned to daily sunscreen developed fewer melanomas over the following years than those who used it whenever they chose 6Ref 6Green AC, Williams GM, Logan V, Strutton GM (2011).Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up.In the long-term follow-up of a randomized trial, daily sunscreen use reduced melanoma incidence compared with discretionary use.. Broader sun protection — shade in the middle of the day, clothing and hats, and avoiding tanning beds — works on the same ultraviolet exposure that drives most skin cancers 3Ref 3National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025).Skin Cancer Prevention (PDQ®)–Health Professional Version.Ultraviolet exposure (sun, sunlamps, tanning beds) is a modifiable risk factor for skin cancer, so reducing UV remains relevant after treatment..

Two groups warrant an especially careful watch. People whose immune systems are suppressed — after an organ transplant, or on certain long-term medications — carry higher risk; the link between immunosuppression and skin cancer is well established, and these patients are often followed more closely and for longer. And because melanoma can arise on the palms, soles, and under the nails — sites that are easy to forget and that matter especially for skin cancer in skin of color — a complete check includes them every time. None of this replaces the schedule your clinician set. It makes the time between visits count, so that if a new spot appears, you notice it while it is still small.